Profile
Clave is a venture capital firm based in Pamplona, Spain, with 20 years of experience. The firm was founded with a focus on driving technological transfer projects, industrial SMEs, and renewable energy projects. The firm has made over 90 investments and currently manages approximately €90 million. Clave emphasizes close collaboration with promoters, management teams, investors, and the innovation ecosystem to support the growth of companies and tackle new market challenges. The team, comprising experienced professionals from various backgrounds, brings a wealth of expertise to its portfolio companies.
Clave invests primarily in sectors such as healthcare, medtech, ehealth, nutrition, and biotech, with a geographical focus on Europe. The firm recently launched a new Tech Transfer Health Fund worth €80 million, backed by CDTI’s INNVIERTE program and other private investors. Clave targets diverse stages, mainly focusing on tech transfer and early to growth stage investments. It strategically partners with institutions and investors to leverage its funds and expertise to support innovative ideas and business growth.
Notable investments include EverSens - respiratory health diagnostics, Innoprick - healthcare solutions, Abanza Tecnomed - medical devices, Polimerbio - biodegradable polymers, and Predictheon - predictive diagnostics. Clave supports these and other companies through active involvement and strategic guidance, ensuring they are well-positioned for future growth.
Industry
Clave Funds
| Name | Type |
|
|
|
Size | AUM | Launch date |
|---|---|---|---|---|---|---|---|
|
Tech Transfer Health Fund
|
Venture Capital (VC)
|
Biotechnology
Foodtech
MedTech
HealthTech
|
Series A
Late Stage (Series C+)
|
Europe
|
$10-50 m
|
—
|
September 2026
|
Contacts
Instant access on the web. Plans from $129/month — see pricing.